Financial Reports Latest Updates Industry Maps Economic Calendar

GeneDx Holdings Corp. (WGS) Annual Reports

Q: Where can I read GeneDx Holdings Corp. (WGS) annual reports?

Every year on this page links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser. 3 filings are currently indexed.

Q: What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer; a 20-F is filed by foreign private issuers (Taiwanese companies with US ADRs, such as TSMC, file 20-F). A 40-F applies to Canadian issuers under the MJDS.

GeneDx Holdings Corp. is listed on Nasdaq, classified by the SEC under Services-Health Services (SIC 8000). This page indexes 3 annual reports, each linking to the full text on the SEC's EDGAR system.

Company profile

Exchange： Nasdaq
Fiscal year end： 12/31
SEC CIK： 1818331 →

Website：Official site ↗

Financial Highlights

FY2026 Q2 (quarterly, ended 2026-06-30)
	Current	Prior year	YoY
Revenue	$114.4M	$102.7M	+11.4%
Operating income	$-17.5M	$9.0M	-294.8%
Net income	$-17.7M	$10.8M	-264.1%
EPS (diluted)	$-0.60	$0.36	-266.7%

Source: SEC EDGAR (XBRL company facts)

Financial history

Revenue & profit

Quarterly · In mn (USD)

Revenue 114 mn Net income -17.7 mn

Show table：Income statement

Item	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Revenue	196	46.7	30.1	38.6	64.0	64.2	47.0	43.2	57.8	53.9	36.2	83.2	61.4	43.1	48.7	53.3	57.4	62.4	70.5	76.9	95.6	87.1	103	117	121	102	114
Gross profit	82.8	9.52	-4.40	2.08	-5.67	-4.32	-1.16	-15.6	-2.81	5.63	-29.6	13.6	-16.3	15.2	18.8	25.3	30.8	37.4	43.0	47.8	66.2	58.5	70.9	84.5	84.3	68.2	78.2
Operating income	-30.4	-26.8	-34.2	-0.06	-125	-1.85	-1.28	-89.6	-116	-89.3	-163	-90.8	-325	-60.4	-51.6	-43.0	-25.6	-13.7	-10.6	-7.78	8.81	-4.55	8.96	-3.25	-14.2	-57.5	-17.4
Net income	-29.7	-27.0	-32.0	-0.06	-126	-58.5	13.0	31.4	-40.2	-76.9	-85.7	-77.6	-309	-61.0	-46.7	-42.3	-25.8	-20.2	-29.2	-8.31	5.44	-6.53	10.8	-7.63	-17.7	-63.3	-17.7

Balance sheet

Quarterly · In mn (USD)

Total assets 481 mn Total liabilities 237 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Current assets	—	—	—	1.47	1.37	0.92	0.4	539	484	410	403	307	213	272	213	172	182	163	162	186	198	226	205	238	268	271	246
Total assets	—	—	—	444	444	444	443	603	554	518	933	829	491	545	476	417	419	395	389	409	419	446	464	494	524	506	481
Current liabilities	—	—	—	0.04	0.1	1.49	2.24	71.4	101	101	205	162	144	119	84.4	68.4	58.8	50.7	68.3	77.3	54.8	69.5	71.4	87.6	109	87.6	74.6
Total liabilities	—	—	—	15.5	15.6	144	130	212	166	188	296	268	237	217	180	163	191	187	195	204	174	189	187	202	216	252	237
Equity	-88.7	—	-148	5.00	5.00	5.00	5.00	391	388	329	637	561	254	328	296	254	228	207	194	205	245	257	277	292	308	254	244

Cash flow

Quarterly · In mn (USD)

Operating -29.0 mn Investing -5.63 mn Financing 1.00 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating	-18.7	—	—	-0.37	-0.02	-0.47	-0.46	-138	-52.0	-81.5	-84.6	-88.4	-64.7	-55.6	-53.5	-41.2	-29.9	-16.4	-4.50	-4.39	-3.18	10.2	10.4	15.8	-3.09	-32.4	-29.0
Investing	-15.5	—	—	-443	0	-4.99	-4.48	-3.62	-7.69	-3.91	-130	-4.28	-2.84	-0.46	-11.3	-27.1	-4.86	0.84	-22.7	-7.75	-0.52	-9.41	-36.4	-4.69	-11.1	-17.3	-5.63
Financing	148	—	—	444	-0.02	-2.28	-2.37	499	-1.03	-0.16	198	-0.65	0.07	133	7.39	-0.91	47.1	-0.44	-0.39	14.0	31.0	13.7	0.35	10.8	23.2	38.6	1.00
Cash at period end	115	—	—	1.14	1.09	0.63	0.17	461	401	315	285	191	124	202	157	87.4	99.7	83.7	56.1	57.9	85.2	99.7	74.1	96.0	105	93.9	60.3

Profitability

Quarterly · %

Gross margin 68.4% Operating margin -15.3% Net margin -15.5%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Gross margin	42.2%	20.4%	-14.6%	5.4%	-8.9%	-6.7%	-2.5%	-36.1%	-4.8%	10.4%	-81.8%	16.3%	-26.6%	35.3%	38.5%	47.4%	53.6%	59.9%	60.9%	62.2%	69.2%	67.1%	69.0%	72.4%	69.7%	66.7%	68.4%
Operating margin	-15.5%	-57.4%	-113.5%	-0.1%	-195.5%	-2.9%	-2.7%	-207.5%	-200.3%	-165.6%	-449.7%	-109.1%	-529.6%	-139.9%	-106.0%	-80.6%	-44.7%	-21.9%	-15.0%	-10.1%	9.2%	-5.2%	8.7%	-2.8%	-11.8%	-56.2%	-15.3%
Net margin	-15.1%	-57.9%	-106.5%	-0.1%	-196.5%	-91.1%	27.7%	72.7%	-69.5%	-142.6%	-237.1%	-93.2%	-503.3%	-141.4%	-95.9%	-79.3%	-44.9%	-32.4%	-41.4%	-10.8%	5.7%	-7.5%	10.5%	-6.5%	-14.6%	-61.9%	-15.5%

Returns & leverage

Quarterly · %

ROE -40.8% ROA -22.5% Debt ratio 49.3%

ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.

Show table：Returns & leverage

Item	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
ROE	—	—	—	-1776.1%	—	-4325.3%	—	-70.5%	-27.6%	-43.5%	-53.4%	-58.9%	-171.1%	-162.1%	-105.9%	-112.5%	-73.0%	-50.4%	-47.9%	-36.4%	-22.1%	-16.6%	0.6%	0.8%	-7.6%	-30.4%	-40.8%
ROA	—	—	—	-20.0%	-41.6%	-48.7%	-38.6%	-26.7%	-10.9%	-15.1%	-24.9%	-39.1%	-105.1%	-100.3%	-70.1%	-73.6%	-38.6%	-28.7%	-27.1%	-20.2%	-12.5%	-9.2%	0.3%	0.5%	-4.5%	-16.3%	-22.5%
Debt ratio	—	—	—	3.5%	3.5%	32.4%	29.4%	35.1%	30.0%	36.4%	31.7%	32.3%	48.3%	39.8%	37.8%	39.1%	45.5%	47.5%	50.1%	50.0%	41.5%	42.3%	40.3%	40.8%	41.1%	49.8%	49.3%

EPS

Quarterly · US$

EPS US$-0.60

Show table：EPS

Item	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
EPS（US$）	-264056.00	—	—	-456573.00	885682.00	-348.82	-41.94	0.15	0.98	-0.31	-0.25	-0.20	-0.88	-3.04	-1.84	-1.64	-0.92	-0.78	-1.10	-0.31	0.23	-0.23	0.36	-0.27	-0.61	-2.16	-0.60

Revenue & profit

Year-to-date · In mn (USD)

Revenue 217 mn Net income -81.1 mn

Year-to-date = summed from the first quarter of the fiscal year; balance-sheet items are period-end balances.

Balance sheet

Year-to-date · In mn (USD)

Total assets 481 mn Total liabilities 237 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Cash flow

Year-to-date · In mn (USD)

Operating -61.4 mn Investing -22.9 mn Financing 39.6 mn

Positive = cash in, negative = cash out.

Profitability

Year-to-date · %

Gross margin 67.6% Operating margin -34.6% Net margin -37.4%

Gross, operating and net margin = the respective profit ÷ revenue.

Returns & leverage

Year-to-date · %

ROE -40.8% ROA -22.5% Debt ratio 49.3%

EPS

Year-to-date · US$

EPS US$-2.76

Revenue & profit

Annual · In mn (USD)

Revenue 428 mn Net income -21.0 mn

Annual = sum of four quarters of a complete fiscal year (incomplete years are omitted); balance-sheet items are year-end balances.

Show table：Income statement

Item	2020	2021	2022	2023	2024	2025
Revenue	179	212	235	203	305	428
Gross profit	1.52	-23.9	-26.8	90.0	194	298
Operating income	-186	-209	-668	-181	-23.2	-13.1
Net income	-185	-54.3	-549	-176	-52.3	-21.0

Balance sheet

Annual · In mn (USD)

Total assets 524 mn Total liabilities 216 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2020	2021	2022	2023	2024	2025
Current assets	1.37	484	213	182	198	268
Total assets	444	554	491	419	419	524
Current liabilities	0.1	101	144	58.8	54.8	109
Total liabilities	15.6	166	237	191	174	216
Equity	5.00	388	254	228	245	308

Cash flow

Annual · In mn (USD)

Operating 33.3 mn Investing -61.5 mn Financing 48.0 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2020	2021	2022	2023	2024	2025
Operating	—	-190	-319	-180	-28.5	33.3
Investing	—	-20.8	-141	-43.7	-30.1	-61.5
Financing	—	494	197	186	44.2	48.0
Cash at period end	1.09	401	124	99.7	85.2	105

Profitability

Annual · %

Gross margin 69.7% Operating margin -3.1% Net margin -4.9%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2020	2021	2022	2023	2024	2025
Gross margin	0.8%	-11.3%	-11.4%	44.4%	63.6%	69.7%
Operating margin	-103.8%	-98.3%	-284.5%	-89.2%	-7.6%	-3.1%
Net margin	-103.0%	-25.6%	-233.9%	-86.8%	-17.1%	-4.9%

Returns & leverage

Annual · %

ROE -7.6% ROA -4.5% Debt ratio 41.1%

Show table：Returns & leverage

Item	2020	2021	2022	2023	2024	2025
ROE	-3695.6%	-27.6%	-171.1%	-73.0%	-22.1%	-7.6%
ROA	-41.6%	-10.9%	-105.1%	-38.6%	-12.5%	-4.5%
Debt ratio	3.5%	30.0%	48.3%	45.5%	41.5%	41.1%

EPS

Annual · US$

EPS US$-0.75

Show table：EPS

Item	2020	2021	2022	2023	2024	2025
EPS（US$）	—	-389.63	-1.64	-7.44	-1.96	-0.75

Source: SEC EDGAR (XBRL company facts)

Annual reports by year

	10-K
2025	Open full text →
2024	Open full text →
2023	Open full text →

10-K: annual report of a US domestic issuer. Filings are the original documents hosted on SEC EDGAR — this site neither mirrors nor edits them.

FAQ

Where can I read GeneDx Holdings Corp. (WGS) annual reports?

Every year in the table above links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser without downloading anything. 3 filings are currently indexed.

What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer, with sections fixed by law: Item 1 Business, Item 1A Risk Factors, Item 7 Management's Discussion and Analysis. A 20-F is filed by foreign private issuers — Taiwanese companies with US ADRs, such as TSMC, file 20-F rather than 10-K. A 40-F applies to Canadian issuers under the MJDS.

Are earnings call materials available here?

No. Earnings calls are not SEC filings, so US pages on this site cover annual reports only. Taiwan has a mandatory investor-conference disclosure regime, and those materials are indexed under Annual Reports.

Source: US Securities and Exchange Commission (SEC) EDGAR. This site indexes public filings and links to them; it hosts no copies, offers no investment advice, and makes no warranty as to timeliness or completeness.
Back to US annual reports, or see the supply-chain maps.